- CA$10.66m
- CA$10.58m
- 31
- 75
- 45
- 49
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1.05 | 1.82 | 1.86 | 1.26 | 1.38 |
Operating Profit | -1.05 | -1.82 | -1.86 | -1.26 | -1.38 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.03 | -1.8 | -1.82 | -1.24 | -1.08 |
Net Income After Taxes | -1.03 | -1.8 | -1.82 | -1.24 | -1.08 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.03 | -1.8 | -1.82 | -1.24 | -1.08 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.03 | -1.8 | -1.82 | -1.24 | -1.08 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.032 | -0.031 | -0.025 | -0.019 | -0.012 |